We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > FiercePharmaAsia

News List

FiercePharmaAsia—Takeda's cost-saving progress; Dr. Reddy's shortfall fiercepharma
August 04, 2019
Takeda is “well on track” with its cost-cutting goal of saving $2 billion by the end of 2021 as it folds in Shire, Chief Financial Officer Costa Saroukos told investors.
FiercePharmaAsia—Astellas job cuts, GSK vet’s $260M Chinese startup, Sun's Zytiga knockoff fiercepharma
May 28, 2018
Astellas' new CEO is pushing for a round of layoffs in RD and sales and marketing that will cost 600 jobs. GlaxoSmit
Amgen’s China biosim deal, Sovaldi’s Chinese nod, Shanghai Pharma’s Alvogen talks fiercepharma
September 30, 2017
Gilead's Chinese nod for Sovaldi, a potential sale of Alvogen's U.S. business to Shanghai Pharma, and more.